BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+2.2%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.12B
AUM Growth
-$54.3M
(-1.3%)
Cap. Flow
-$25.4M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114
Top Buys
| 1 |
Vir Biotechnology
VIR
|
$12.6M |
| 2 |
Par Pacific Holdings
PARR
|
$12.2M |
| 3 |
Crescent Energy
CRGY
|
$11.8M |
| 4 |
Gulfport Energy Corp
GPOR
|
$11.6M |
| 5 |
Oracle
ORCL
|
$11.4M |
Top Sells
| 1 |
Boise Cascade
BCC
|
$17.7M |
| 2 |
Treehouse Foods
THS
|
$11.5M |
| 3 |
Tri Pointe Homes
TPH
|
$10.5M |
| 4 |
Sterling Infrastructure
STRL
|
$10.3M |
| 5 |
Texas Instruments
TXN
|
$9.45M |
Sector Composition
| 1 | Financials | 25.26% |
| 2 | Consumer Discretionary | 11.91% |
| 3 | Industrials | 11.71% |
| 4 | Technology | 10.55% |
| 5 | Energy | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Information Services Group
III
$253M
| $182K | ﹤0.01% |
41,448
| – | – |
|
1127
Sera Prognostics
SERA
$127M
| $179K | ﹤0.01% |
96,105
+22,800
| +31% | +$42.4K |
|
1128
Sangamo Therapeutics
SGMO
$165M
| $177K | ﹤0.01% |
+295,000
| New | +$177K |
|
1129
Pixelworks
PXLW
$46.2M
| $176K | ﹤0.01% |
12,958
+341
| +3% | +$4.62K |
|
1130
SCYNEXIS
SCYX
$37.3M
| $174K | ﹤0.01% |
76,500
| – | – |
|
1131
Usio Inc
USIO
$37.4M
| $169K | ﹤0.01% |
96,400
| – | – |
|
1132
Aemetis
AMTX
$151M
| $166K | ﹤0.01% |
40,000
-50,000
| -56% | -$208K |
|
1133
Mexco Energy
MXC
$17.6M
| $164K | ﹤0.01% |
12,660
| – | – |
|
1134
Spero Therapeutics
SPRO
$121M
| $163K | ﹤0.01% |
134,800
+25,000
| +23% | +$30.3K |
|
1135
Context Therapeutics
CNTX
$73.6M
| $160K | ﹤0.01% |
105,809
| – | – |
|
1136
Lucid Diagnostics
LUCD
$140M
| $158K | ﹤0.01% |
135,000
| – | – |
|
1137
HCW Biologics
HCWB
$9.12M
| $158K | ﹤0.01% |
2,065
| – | – |
|
|
ICAD
1138
DELISTED
iCAD Inc
ICAD
| $157K | ﹤0.01% |
+74,600
| New | +$157K |
|
|
LUMO
1139
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $157K | ﹤0.01% |
47,643
| – | – |
|
|
SUNW
1140
DELISTED
Sunworks, Inc.
SUNW
| $157K | ﹤0.01% |
302,073
| – | – |
|
|
SYRS
1141
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $156K | ﹤0.01% |
39,500
| – | – |
|
1142
Quince Therapeutics
QNCX
$86.5M
| $155K | ﹤0.01% |
138,495
+83,495
| +152% | +$93.5K |
|
1143
Assembly Biosciences
ASMB
$183M
| $154K | ﹤0.01% |
14,500
| – | – |
|
1144
Crawford & Co Class A
CRD.A
$540M
| $154K | ﹤0.01% |
16,475
+474
| +3% | +$4.43K |
|
1145
Clearside Biomedical
CLSD
$27.2M
| $153K | ﹤0.01% |
175,600
-104,000
| -37% | -$90.5K |
|
1146
Farmer Brothers
FARM
$43.5M
| $151K | ﹤0.01% |
58,700
-29,200
| -33% | -$75.3K |
|
1147
KORE Group Holdings
KORE
$39.5M
| $150K | ﹤0.01% |
49,740
-1,000
| -2% | -$3.03K |
|
1148
Frequency Electronics
FEIM
$308M
| $149K | ﹤0.01% |
21,500
| – | – |
|
1149
Gain Therapeutics
GANX
$63.3M
| $149K | ﹤0.01% |
46,100
| – | – |
|
1150
Retractable Technologies
RVP
$23.7M
| $148K | ﹤0.01% |
124,534
+21,700
| +21% | +$25.8K |
|